Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,707
Closed -$2.58M 349
2017
Q2
$2.58M Sell
10,707
-11,110
-51% -$2.52M 0.14% 177
2017
Q1
$4.5M Sell
21,817
-20,848
-49% -$4.31M 0.21% 149
2016
Q4
$8.71M Sell
42,665
-10,786
-20% -$2.06M 0.35% 80
2016
Q3
$9.46M Sell
53,451
-46,799
-47% -$8.12M 0.29% 102
2016
Q2
$18M Sell
100,250
-38,568
-28% -$6.85M 0.54% 47
2016
Q1
$25.4M Buy
138,818
+8,449
+6% +$1.47M 0.72% 30
2015
Q4
$23.3M Buy
+130,369
New +$22.9M 0.74% 33
2015
Q3
Sell
-41,253
Closed -$7.89M 501
2015
Q2
$7.89M Buy
+41,253
New +$7.66M 0.2% 124
2014
Q3
Sell
-123,615
Closed -$15.8M 449
2014
Q2
$15.8M Buy
123,615
+5,501
+5% +$651K 0.38% 78
2014
Q1
$13.3M Buy
+118,114
New +$12.3M 0.26% 108
2013
Q3
Sell
-15,664
Closed -$1.32M 213
2013
Q2
$1.32M Buy
+15,664
New +$1.24M 0.05% 196

Other funds holding HUM

GLG Partners's HUM Position: Q3 2017 in Review

GLG Partners sold out of Humana (HUM) in Q3 2017, closing a stake of 10,707 shares — an estimated $2.58M sold.

GLG Partners first reported a position in HUM in Q2 2013 and held it in 11 quarters. The position peaked at $25.4M in Q1 2016. 655 funds tracked by Wall St. Rank hold HUM as of Q3 2017.

  • GLG Partners reported no remaining Humana position as of Q3 2017 after selling out during the quarter.
  • GLG Partners sold 10,707 Humana shares in Q3 2017, an estimated $2.58M.
  • GLG Partners first reported a position in Humana in Q2 2013 and held it in 11 quarters.
  • GLG Partners's Humana position peaked at $25.4M in Q1 2016.
  • 655 funds tracked by Wall St. Rank held Humana as of Q3 2017.

Based on GLG Partners's 13F filing for Q3 2017, filed 14 Nov 2017.